End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.8 CNY | +1.49% | +6.82% | -7.72% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.72% | 1.54B | - | ||
-4.91% | 182B | C+ | ||
+0.46% | 110B | C | ||
-3.62% | 67.92B | A | ||
+3.26% | 50.96B | B- | ||
+9.11% | 44.7B | B- | ||
+2.70% | 40.66B | B+ | ||
+6.39% | 27.6B | B | ||
+3.83% | 26.63B | A- | ||
+13.67% | 24.84B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 600587 Stock
- Ratings Shinva Medical Instrument Co.,Ltd.